Private Equity
European venture firm Lakestar has raised 350 million euros (about $398 million) for its oversubscribed second fund. Lakestar II will focus mostly on early-stage or growth-stage investments. Monument Group was the placement agent.
3 min read · 24 August 2015
Versant Ventures has launched its third life sciences incubator with an eye toward developing a new generation of biotech startups linked to top academic institutions in the Northeast United States.
1 min read · 24 August 2015
Meanwhile, confidence is slumping
3 min read · 22 August 2015
The summer investment slowdown arrived this year with the warm weather, as it does most years. But you would hardly know it from the pace of activity in the venture business.
2 min read · 21 August 2015
Lerer Hippeau Ventures is back in the market for its fifth fund, a year after closing its fourth, according to an SEC filing.
1 min read · 21 August 2015
San Francisco-based accelerator IndieBio focuses on helping bring new bio-engineered products to market, like milk and eggs.
2 min read · 21 August 2015
Point Judith Capital is seeking $100 million for its fourth venture fund, according to a Form D SEC filing. The early-stage Boston-based venture firm focuses on software and technology enabled services.
1 min read · 21 August 2015
Google Ventures, Kleiner Perkins Caufield & Byers and Icon Ventures invest $17 million in San Francisco-based Zephyr Health, which provides big data services for pharmaceutical and medical device companies.
2 min read · 21 August 2015
David Teten of ff Venture Capital interviews Mari Joller on how corporates are innovating and impacting venture capital
9 min read · 21 August 2015
San Francisco company has now raised more than $33 million in funding
2 min read · 20 August 2015
